Deepak Cyril D'Souza, MBBS, MD

Professor of Psychiatry; Director Schizophrenia Neuropharmacology Research Group at Yale (SNRGY); Director, Neurobiological Studies Unit, VACHS; Director, VA-CMHC Schizophrenia Research Clinic

Departments & Organizations

Psychiatry: Clinical Neuroscience Research Unit | Neuroscience Research Training Program (NRTP) | Schizophrenia Research Clinic | Yale Global Mental Health Program

Faculty Research

Office of Cooperative Research

Biography

Deepak Cyril D’Souza, MD is a staff psychiatrist at VA Connecticut Healthcare System (VACHS) and Professor of Psychiatry, Yale University School of Medicine. He is an active clinician, teacher and researcher, who has spent almost 25 years within VACHS.

As an active clinician and clinical administrator, he directs the Neuropsychiatry Program at VACHS, the clinical service that cares for veterans with psychotic, mood and personality disorders.

He is actively involved in teaching residents, fellows and other trainees, and directs the VA Schizophrenia Research Fellowship program. He also mentors a number of junior faculty.

He directs the Schizophrenia Neuropharmacology Research Group at Yale (SNRGY) and the Neurobiological Studies Unit. His research focus has been on the pathophysiology and treatment of psychotic disorders, and cannabis dependence using a combination of psychopharmacological, brain imaging and electrophysiological approaches. His research has been funded by the National Institute of Drug Abuse, the National Institute of Mental Health, the National Institute of Alcoholism and Alcohol Abuse, VA R&D and several foundations. He is recognized as a leading expert in the relationship between cannabinoids and psychosis.

Education & Training

MD SUNY at Brooklyn (1992)
MBBS St. John's Medical College, India (1986)

Professional Service

  • Interim Chief of Psychiatry VA Connecticut Healthcare System (2010)

International Activity

  • Cognitive Rehabilitation in Schizophrenia - D-serine Facilitation India (2008)

    Clinical trial of the combination of D-serine (Gly site agonist) and computerized cognitive retraining to improve cognition in individuals with schizophrenia

Edit this profile

Contact Info

Deepak Cyril D'Souza, MBBS, MD
Mailing Address
Psychiatry Service 116A, VACHS950 Campbell Avenue
West Haven, CT 06516